Candriam S.C.A.

Position in REPL — Replimune Group, Inc.

CIK 1537014 STRASSEN, N4

Position in REPL

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$3,014,306

+$1,420,821 QoQ

Shares Held

394,027

+129.7% QoQ

Ownership

0.418%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	195,674	$122,010,565
2	RVMD	Revolution Medicines, Inc.	556,392	$104,201,093
3	VRTX	Vertex Pharmaceuticals Inc / Ma	199,505	$99,100,118
4	ALNY	Alnylam Pharmaceuticals, Inc.	314,512	$94,677,547
5	ONC	BeOne Medicines Ltd.	289,735	$82,565,782
6	COGT	Cogent Biosciences, Inc.	2,088,369	$80,819,880
7	ARGX	Argenx SE	80,120	$74,332,932
8	ROIV	Roivant Sciences Ltd.	1,990,510	$70,444,148

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,014,306	394,027	+129.7%	Shares	Sole	2026-04-30
2025-06-30	$1,593,485	171,527	-72.0%	Shares	Sole	2025-08-08
2023-09-30	$10,474,621	612,193	0.0%	Shares	Sole	2023-11-13
2023-06-30	$14,215,120	612,193	-7.7%	Shares	Sole	2023-08-08
2023-03-31	$11,707,202	662,922	0.0%	Shares	Sole	2023-05-12
2022-12-31	$18,031,478	662,922	+8.8%	Shares	Sole	2023-02-13
2022-09-30	$10,527,308	609,572	+23.8%	Shares	Other	2022-11-10
2022-06-30	$8,608,969	492,504	0.0%	Shares	Sole	2022-08-03
2022-03-31	$8,362,717	492,504	-5.2%	Shares	Other	2022-05-13
2021-12-31	$14,078,774	519,512	-0.5%	Shares	Sole	2022-02-10
2021-09-30	$15,476,258	522,141	+7.4%	Shares	Sole	2021-11-09
2021-06-30	$18,671,658	485,988	+199.7%	Shares	Sole	2021-07-20
2021-03-31	$4,947,501	162,160	+0.0%	Shares	Other	2021-04-29
2020-12-31	$6,186,174	162,154	—	Shares	Sole	2021-01-22
No filing history on record for this holder in this stock.